Elizabeth Arden, Inc. Announces Fourth Quarter and Fiscal 2013 Results

  Elizabeth Arden, Inc. Announces Fourth Quarter and Fiscal 2013 Results

                 ~ Fiscal 2013 Net Sales of $1.345 Billion ~

                 ~ Increase of 8.6%; 9.6% at Constant Rates ~

Business Wire

NEW YORK -- August 8, 2013

Elizabeth Arden, Inc. (NASDAQ: RDEN), a global prestige beauty products
company, today announced financial results for its fourth fiscal quarter and
fiscal year ended June 30, 2013.

FISCAL 2013 RESULTS

For the fiscal year ended June 30, 2013, the Company reported net sales of
$1.345 billion or an increase of 8.6% as compared to the prior fiscal year. At
constant rates, net sales increased by 9.6%. On a reported basis, net income
per diluted share was $1.33. On an adjusted basis, net income per diluted
share was $2.14, as compared to net income per diluted share of $2.07 for the
prior year period. Adjusted net income per diluted share excludes
non-recurring costs relating to the Elizabeth Arden repositioning and the
fiscal 2012 fragrance brand acquisitions. A reconciliation between GAAP and
adjusted results can be found in the tables and footnotes at the end of this
press release.

In North America, net sales increased 10.2% over the prior fiscal year, and
net sales for the Company’s international segment increased by 8.4% (at
constant rates). Net sales of fragrances in the international segment
increased 14% (at constant rates) for fiscal 2013 behind the Company's Western
European fragrance initiative and expansion into new markets.

The Company continued to see success with the Elizabeth Arden repositioning.
Retail sales at the Company's Elizabeth Arden flagship counters have increased
20% in North America year over year since conversion, and retail sales at the
Company’s international flagship doors have increased 17% in the aggregate
since conversion. These increases are driven by the retail sales performance
of skin care and color products.

E. Scott Beattie, Chairman, President and Chief Executive Officer of Elizabeth
Arden, Inc., commented, “There were two primary factors that caused our sales
and earnings results to be below our expectations in fiscal 2013. The first
was due to weakness at one of our largest North American mass retail
customers, both in terms of retail sales performance and replenishment rate.
The second factor was that are growth projections for the Elizabeth Arden
brand proved to be overly optimistic given the complexity and scope of
transition underway for the brand repositioning. We remain confident in our
repositioning efforts and, in fact, are accelerating the execution of the
Elizabeth Arden brand repositioning. We expect to incur the final phase of
repositioning expenses, including eliminating pre-repositioned product
inventory and exiting unprofitable doors, in fiscal 2014. While resulting in
near term charges, this is expected to drive improved performance of the
Elizabeth Arden brand going forward. Separately, we are taking steps to
improve efficiencies in our sales organizations and in the overall indirect
overhead structure.”

Mr. Beattie continued, “While this was a transitional year for our company, we
did make good progress driving both our Western European fragrance initiative
and significantly enhancing the future prospects of the Elizabeth Arden brand
through the brand repositioning. We also integrated the fragrance brands
acquired late in fiscal 2012, grew our category-leading market share of
fragrances at mass retail in North America, opened affiliates in new markets,
including Brazil and Germany, and restructured our business in China.”

Mr. Beattie concluded, “Our priorities remain to accelerate the global growth
of the Elizabeth Arden brand, expand sales of our fragrance portfolio,
particularly internationally, and continue to drive operational efficiencies.
Many of the initiatives we are undertaking to expand our business, while not
accretive in fiscal 2014, are important to drive future growth. I am confident
that with the acquisitions and restructuring activities, including those
associated with the Elizabeth Arden brand repositioning, behind us and more
conservative forward guidance, we will return to systematic improvement in
gross margins, EBITDA margins and return on invested capital.”

FOURTH QUARTER RESULTS

For the fourth quarter ended June 30, 2013, the Company reported net sales of
$267.6 million, or an increase of 0.8%, as compared to the prior year period.
At constant rates, net sales increased by 1.2%. On a reported basis, net loss
per diluted share was $0.17. On an adjusted basis, net income per diluted
share was $0.10, as compared to net income per diluted share of $0.28 for the
prior year period. Adjusted net income per diluted share excludes
non-recurring costs as noted above.

During the fourth quarter, the Company experienced lower than expected
replenishment orders from one of its key North American mass retail customers,
effectively reducing their inventory on hand with orders significantly below
their pace of their retail sales of the Company’s products. The replenishment
rate at this account worsened significantly in the month of June. The impact
from this customer, coupled with weak performance in Europe, particularly in
the UK, caused the fourth quarter and full year earnings results to be below
the expectations communicated last May. The remainder of the Company’s
business largely performed as expected.

OUTLOOK

The Company’s guidance for fiscal 2014 reflects more modest expectations
regarding the overall Elizabeth Arden brand repositioning, uncertain economic
conditions globally and the quarterly variability of all of the Company’s
initiatives to drive future revenue growth and market share, which span across
the Company’s businesses and geographies. In addition, based on current
foreign currency rates, foreign currency translation is expected to negatively
impact fiscal 2014 results.

For the full fiscal year ending June 30, 2014, the Company expects net sales
to increase by 3.0% to 5.0%, including an expected unfavorable impact from
foreign currency of approximately 1.0%, as compared to the prior year period,
and for earnings per diluted share to be in the range of $2.15 to $2.30. The
earnings guidance includes a negative impact of $0.19 per share resulting from
foreign currency translation as compared to rates in effect for fiscal 2013.

For the first quarter of fiscal 2014 ending September 30, 2013, the Company
expects sales to be flat to down 1% in comparison to the prior year period,
including an unfavorable impact from foreign currency translation of
approximately 1.0%, and for adjusted earnings per diluted share to be in the
range of $0.13 to $0.18.

The gross margin and earnings guidance excludes all non-recurring expenses. In
fiscal 2014, the Company expects to incur non-recurring expenses of $11
million to $16 million for the Elizabeth Arden repositioning, approximately
$7.5 million of which is expected to be incurred in the first quarter. The
Elizabeth Arden repositioning costs primarily relate to product changeover
charges and exiting unprofitable doors. Additionally, the Company expects to
incur approximately $5 million for restructuring and severance charges, $3.5
million of which is expected to be incurred in the first quarter.

The Company notes that continued global economic uncertainty may have a
negative effect on retailer and consumer confidence and demand, and, along
with the foreign currency volatility, makes forecasting difficult.

CONFERENCE CALL INFORMATION

The Company will host a conference call on Thursday, August 8, 2013 at 9:30
a.m. Eastern Time. All interested parties can listen to a live web cast of the
Company's conference call by visiting the Investor Relations section of the
Corporate tab on the Company's web site at http://ir.elizabetharden.com. An
online archive of the broadcast will be available within one hour of the
completion of the call and will be accessible on the Company's web site until
September 8, 2013.

Elizabeth Arden is a global prestige beauty products company with an extensive
portfolio of prestige beauty brands sold in over 100 countries. The company's
brand portfolio includes Elizabeth Arden skincare, color and fragrance
products, the celebrity fragrance brands of Britney Spears, Elizabeth Taylor,
Justin Bieber, Mariah Carey, Nicki Minaj, Taylor Swift, and Usher; the
designer fragrance brands of Juicy Couture, Alfred Sung, BCBGMAXAZRIA,
Geoffrey Beene, Halston, Bob Mackie, Ed Hardy, John Varvatos, Lucky Brand,
True Religion and Rocawear; and the lifestyle fragrance brands Curve, Giorgio
Beverly Hills, and PS Fine Cologne.

                                              
ELIZABETH ARDEN, INC. AND SUBSIDIARIES
CONSOLIDATED STATEMENT OF OPERATIONS DATA
(Unaudited)
(In thousands, except percentages and per share data)
                                                                             
                     Three Months Ended          Twelve Months Ended
                     June 30,     June 30,      June 30,       June 30,
                     2013          2012          2013            2012
                                                                             
Net Sales            $ 267,579     $ 265,534     $ 1,344,523     $ 1,238,273
                                                                             
Cost of Goods
Sold:
Cost of Sales          147,124       134,437       709,344         623,985
Depreciation
Related to Cost of   1,712         1,407         6,386           5,257
Goods Sold
Total Cost of          148,836       135,844       715,730         629,242
Goods Sold
                                                                             
Gross Profit           118,743       129,690       628,793         609,031
Gross Profit           44.4    %     48.8    %     46.8      %     49.2      %
Percentage
                                                                             
Selling, General
and Administrative     112,993       113,483       517,250         484,963
Expenses
Depreciation and     10,828        7,364         39,583          28,797
Amortization
Total Operating        123,821       120,847       556,833         513,760
Expenses
                                                                             
Interest Expense,      5,794         5,420         24,309          21,759
Net
                                                                             
(Loss) Income
Before Income          (10,872 )     3,423         47,651          73,512
Taxes
(Benefit from)
Provision for        (5,863    )   (202      )   6,940           16,093
Income Taxes
Net (Loss) Income    $ (5,009  )   $ 3,625       $ 40,711        $ 57,419
                                                                             
Net (Loss) Income    $ (0.17   )   $ 0.12        $ 1.37          $ 1.97
Per Basic Share
Net (Loss) Income    $ (0.17   )   $ 0.12        $ 1.33          $ 1.91
Per Diluted Share
                                                                             
Basic Shares           29,514        29,223        29,672          29,115
Diluted Shares         29,514        30,197        30,539          30,111
                                                                             
EBITDA (a)           $ 7,462       $ 17,614      $ 117,929       $ 129,325
EBITDA margin (a)      2.8     %     6.6     %     8.8       %     10.4      %
                                                                             
Adjusted to
exclude
non-recurring
costs, net of
taxes (b)(c):
                                                                             
Gross Profit         $ 131,570     $ 134,638     $ 665,148       $ 613,979
Gross Profit           49.2    %     50.7    %     49.5      %     49.6      %
Percentage
                                                                             
Net Income           $ 3,121       $ 8,550       $ 65,335        $ 62,344
                                                                             
Net Income Per       $ 0.11        $ 0.29        $ 2.20          $ 2.14
Basic Share
Net Income Per       $ 0.10        $ 0.28        $ 2.14          $ 2.07
Diluted Share
                                                                             
EBITDA (a)           $ 21,845      $ 24,722      $ 156,714       $ 136,433
EBITDA margin (a)      8.2     %     9.3     %     11.7      %     11.0      %

(a) EBITDA is defined as net income plus the provision for income taxes (or
net loss less the benefit from income taxes) plus interest expense, plus
depreciation and amortization. EBITDA should not be considered as an
alternative to income from operations or net income (loss) (as determined in
accordance with generally accepted accounting principles (GAAP)) as a measure
of our operating performance or to net cash provided by operating, investing
and financing activities (as determined in accordance with GAAP) or as a
measure of our ability to meet cash needs. We believe that EBITDA is a measure
commonly reported and widely used by investors and other interested parties as
a measure of a company's operating performance and debt servicing ability
because it assists in comparing performance on a consistent basis without
regard to capital structure, depreciation and amortization or non-operating
factors (such as historical cost). Accordingly, as a result of our capital
structure, we believe EBITDA is a relevant measure. This information has been
disclosed here to permit a more complete comparative analysis of our operating
performance relative to other companies and of our debt servicing ability.
EBITDA may not, however, be comparable in all instances to other similar types
of measures. We have also disclosed EBITDA as adjusted without giving effect
to acquisition-related and Elizabeth Arden repositioning costs. This
disclosure is being provided for comparability purposes because we believe it
is meaningful to our investors and other interested parties to understand the
EBITDA performance of the Company on a consistent basis without regard to the
effect of acquisition-related and Elizabeth Arden repositioning costs.

The table below reconciles net (loss) income, as determined in accordance with
GAAP, to EBITDA and to EBITDA as adjusted: (For a reconciliation of net income
to EBITDA for prior periods, see our filings with the Securities and Exchange
Commission which can be found on our website at www.elizabetharden.com.)

(Amounts in thousands)      Three Months Ended       Twelve Months Ended
                             June 30,    June 30,     June 30,    June 30,
                             2013         2012         2013          2012
Net (loss) income            $ (5,009 )   $ 3,625      $ 40,711      $ 57,419
Plus:
(Benefit from) Provision       (5,863 )     (202   )     6,940         16,093
for income taxes
Interest expense, net          5,794        5,420        24,309        21,759
Depreciation related to        1,712        1,407        6,386         5,257
cost of goods sold
Depreciation and             10,828       7,364        39,583        28,797
amortization
EBITDA                         7,462        17,614       117,929       129,325
Non-recurring costs (c)      14,383       7,108        38,785        7,108
EBITDA, as adjusted          $21,845      $24,722      $156,714      $136,433

The table below reconciles net cash flow provided by operating activities, as
determined in accordance with GAAP, to EBITDA:

(Amounts in thousands)                              Twelve Months Ended
                                                     June 30,     June 30,
                                                     2013          2012
                                                                             
Net cash provided by operating activities            $ 62,091      $ 58,524
Changes in assets and liabilities, net of              30,508        48,016
acquisitions
Interest expense, net                                  24,309        21,759
Amortization of senior note offering and credit        (1,367  )     (1,247  )
facility costs
Provision for income taxes                             6,940         16,093
Deferred income taxes                                  1,055         (8,763  )
Amortization of share-based awards                   (5,607    )   (5,057    )
                                                                             
EBITDA                                               $ 117,929     $ 129,325

(b) The table below reconciles the calculation of (i) gross profit and net
(loss) income and (ii) net (loss) income per share on a basic and diluted
basis from the amounts reported in accordance with GAAP to such amounts before
giving effect to non-recurring costs related to the Elizabeth Arden brand
repositioning and our 2012 fragrance license acquisitions. This disclosure is
being provided for comparability purposes because we believe it is meaningful
to our investors and other interested parties to understand our operating
performance on a consistent basis without regard to the effect of such
non-recurring costs. The presentation in the table below of the non-GAAP
information titled "Gross profit as adjusted", "Net income as adjusted" and
"Net income per basic and diluted share as adjusted" is not meant to be
considered in isolation or as a substitute for gross profit, net (loss) income
or net (loss) income per basic and diluted share prepared in accordance with
GAAP.

(In thousands, except    Three Months Ended         Twelve Months Ended
per share data)
                          June 30,     June 30,     June 30,    June 30,
                           2013          2012          2013          2012
Gross Profit:
Gross Profit as reported   $ 118,743     $ 129,690     $ 628,793     $ 609,031
Non-recurring costs (c)     12,827       4,948        36,355       4,948
Gross Profit as adjusted   $ 131,570     $ 134,638     $ 665,148     $ 613,979
Net (Loss) Income:
Net (loss) income as       $ (5,009  )   $ 3,625       $ 40,711      $ 57,419
reported
Non-recurring costs (c)    8,130         4,925         24,624        4,925
(d)
Net income as adjusted     $ 3,121       $ 8,550       $ 65,335      $ 62,344
                                                                       
Net Income Per Basic
Share:
Net (loss) income per      $ (0.17   )   $ 0.12        $ 1.37        $ 1.97
basic share as reported
Non-recurring costs, net   0.28          0.17          0.83          0.17
of tax (c) (d)
Net income per basic       $ 0.11        $ 0.29        $ 2.20        $ 2.14
share as adjusted
                                                                       
Net Income Per Diluted
Share:
Net (loss) income per
diluted share as           $ (0.17   )   $ 0.12        $ 1.33        $ 1.91
reported
Non-recurring costs, net   0.27          0.16          0.81          0.16
of tax (c) (d)
Net income per diluted     $ 0.10        $ 0.28        $ 2.14        $ 2.07
share as adjusted

(c) For the three months ended June 30, 2013, gross profit includes $12.9
million (pre-tax) of non-recurring product changeover costs and product
discontinuation charges related to the repositioning of the Elizabeth Arden
brand. In addition, net loss includes $1.5 million (pre-tax) of expenses
related to a third party provider of freight audit and payment services that
entered into bankruptcy after receiving funds from us to pay our freight
invoices and breaching its obligation to remit those funds to the freight
companies.

For the twelve months ended June 30, 2013, gross profit includes $13.8 million
(pre-tax) of inventory-related costs ($6.4 million of which did not require
the use of cash in the current period) primarily for inventory we purchased
from New Wave Fragrances LLC and Give Back Brands LLC prior to the fragrance
license acquisitions from those companies (the “2012 acquisitions”), and $22.6
million (pre-tax) of non-recurring product changeover costs and product
discontinuation charges related to the repositioning of the Elizabeth Arden
brand. In addition, net income includes (i) $0.4 million (pre-tax) in
transition costs associated with the 2012 acquisitions, (ii) $0.5 million
(pre-tax) of expenses related to the repositioning of the Elizabeth Arden
brand and (iii) $1.5 million (pre-tax) of expenses related to a third party
provider of freight audit and payment services that entered into bankruptcy
after receiving funds from us to pay our freight invoices and breaching its
obligation to remit those funds to the freight companies.

For the three and twelve months ended June 30, 2012, gross profit includes
$4.5 million (pre-tax) of inventory-related costs primarily for inventory we
purchased from New Wave Fragrances LLC and Give Back Brands LLC prior to the
2012 acquisitions and other transition costs, and $0.4 million (pre-tax) for
product discontinuation charges. In addition, net income includes $1.4 million
(pre-tax) in license termination costs and $0.8 million (pre-tax) in
transaction costs associated with the 2012 acquisitions.

(d) Our effective tax rate on a reported basis, which is calculated as a
percentage of (loss) income before income taxes, was 53.9% and 14.6% for the
three and twelve months ended June 30, 2013, respectively. On an adjusted
basis, our effective tax rate was 11.1%.and 24.4% for the three and twelve
months ended June 30, 2013, respectively. On a reported basis, for the three
and twelve months ended June 30, 2012, our effective tax rate was 5.9% and
21.9%, respectively. On an adjusted basis, for the three and twelve months
ended June 30, 2012, our effective tax rate was 18.8% and 22.7%, respectively.

                              SEGMENT NET SALES

The table below is a comparative summary of our net sales by reportable
segment for the three and twelve months ended June 30, 2013 and 2012:

(In            Three Months Ended     % Increase          Twelve Months Ended        % Increase
thousands)                              (Decrease)                                       (Decrease)
                June 30,    June 30,            Constant     June 30,      June 30,              Constant
                2013       2012        GAAP   Rates        2013         2012          GAAP   Rates
                                                (e)                                              (e)
Segment Net                                                                                  
Sales
North America   $ 156,150   $ 153,192   1.9  %  2.0      %   $ 857,531     $ 778,407     10.2%   10.2%
International    111,429   112,342   (0.8 )% 0.1      %     486,992     459,866     5.9%   8.4%
Total           $ 267,579   $ 265,534   0.8  %  1.2      %   $ 1,344,523   $ 1,238,273   8.6%    9.6%

                          PRODUCT CATEGORY NET SALES

The table below is a comparative summary of our net sales by product category
for the three and twelve months ended June 30, 2013 and 2012:

(In         Three Months Ended     % Increase           Twelve Months Ended        % Increase
thousands)                           (Decrease)                                        (Decrease)
             June 30,    June 30,            Constant      June 30,      June 30,              Constant
             2013       2012        GAAP   Rates         2013         2012          GAAP   Rates
                                             (e)                                               (e)
Product
Category                                                              
Net Sales:
Elizabeth
Arden        $ 115,345   $ 120,697   (4.4 )% (3.9     )%   $ 478,020     $ 484,645     (1.4) % 0.1%
Brand
Celebrity,
Lifestyle,
Designer      152,234   144,837   5.1  %  5.5      %      866,503     753,628     15.0  % 15.7%
and
Other
Fragrances
Total        $ 267,579   $ 265,534   0.8  %  1.2      %    $ 1,344,523   $ 1,238,273   8.6   % 9.6%

(e) Constant currency information compares results between periods assuming
exchange rates had remained constant period-over-period and excludes gains and
losses from foreign currency contracts in all periods. We calculate constant
currency information by translating current-period results using prior-year
GAAP foreign currency exchange rates. The gains and/or losses from foreign
currency contracts were not material for all periods presented.

                                                                
ELIZABETH ARDEN, INC. AND SUBSIDIARIES
CONSOLIDATED BALANCE SHEET DATA
(Unaudited)
                                                                   
(In thousands)                                       June 30,      June 30,
                                                     2013          2012
Cash                                                 $ 61,674      $ 59,080
Accounts Receivable, Net                               211,763       188,141
Inventories                                            310,934       291,987
Property and Equipment, Net                            106,588       89,438
Exclusive Brand Licenses, Trademarks and               296,416       314,502
Intangibles, Net
Goodwill                                               21,054        21,054
Total Assets                                           1,103,732     1,066,754
Short-Term Debt                                        88,000        89,200
Current Liabilities                                    293,359       278,679
Long-Term Liabilities                                  295,091       306,348
Long-Term Debt                                         250,000       250,000
Shareholders' Equity                                   515,282       481,727
Working Capital                                        364,320       345,818

                                                 
SUPPLEMENTARY CASH FLOW INFORMATION
(Unaudited)
(In thousands)
                                                                             
                                                    Twelve Months Ended
                                                    June 30,     June 30,
                                                    2013          2012
Net cash provided by operating activities           $ 62,091      $ 58,524
Net cash used in investing activities                 (48,591 )     (153,224 )
Net cash (used in) provided by financing              (9,214  )     96,760
activities
Net increase in cash and cash equivalents             2,594         230

In connection with the safe harbor provisions of the Private Securities
Litigation Reform Act of 1995, Elizabeth Arden, Inc. is hereby providing
cautionary statements identifying important factors that could cause our
actual results to differ materially from those projected in forward-looking
statements (as defined in such act). Any statements that are not historical
facts and that express, or involve discussions as to, expectations, beliefs,
plans, objectives, assumptions or future events or performance (often, but not
always, indicated through the use of words or phrases such as "will likely
result," "are expected to," "will continue," "is anticipated," "should,"
"estimated," "intends," "plans," "believes" and "projects") may be
forward-looking and may involve estimates and uncertainties which could cause
actual results to differ materially from those expressed in the
forward-looking statements. These statements include, but are not limited to,
our guidance and expectations regarding net sales, earnings, gross margins,
EBITDA margins, operating cash flow and returns on invested capital. In
addition, any such statements are qualified in their entirety by reference to,
and are accompanied by, the following key factors that have a direct bearing
on our results of operations:

    factors affecting our relationships with our customers or our customers'
    businesses, including the absence of contracts with customers, our
    customers' financial condition, and changes in the retail, fragrance and
*  cosmetic industries, such as the consolidation of retailers and the
    associated closing of retail doors as well as retailer inventory control
    practices, including, but not limited to, levels of inventory carried at
    point of sale and practices used to control inventory shrinkage;
    risks of international operations, including foreign currency
    fluctuations, hedging activities, economic and political consequences of
*   terrorist attacks, disruptions in travel, unfavorable changes in U.S. or
    international laws or regulations, diseases and pandemics, and political
    instability in certain regions of the world;
*   our reliance on license agreements with third parties for the rights to
    sell many of our prestige fragrance brands;
    our reliance on third-party manufacturers for substantially all of our
*   owned and licensed products and our absence of contracts with suppliers of
    distributed brands and components for manufacturing of owned and licensed
    brands;
    delays in shipments, inventory shortages and higher supply chain costs due
*   to the loss of or disruption in our distribution facilities or at key
    third party manufacturing or fulfillment facilities that manufacture or
    provide logistic services for our products;
    our ability to respond in a timely manner to changing consumer preferences
*   and purchasing patterns and other international and domestic conditions
    and events that impact retailer and/or consumer confidence and demand,
    such as domestic or international recessions or economic uncertainty;
*   our ability to protect our intellectual property rights;
*   our ability to successfully manage our inventories;
*   the success, or changes in the timing or scope, of our new product
    launches, advertising and merchandising programs;
*   the quality, safety and efficacy of our products;
*   the impact of competitive products and pricing;
    our ability to (i) implement our growth strategy and acquire or license
    additional brands or secure additional distribution arrangements, (ii)
*   successfully and cost-effectively integrate acquired businesses or new
    brands, and (iii) finance our growth strategy and our working capital
    requirements;
    our level of indebtedness, our ability to realize sufficient cash flows
*   from operations to meet our debt service obligations and working capital
    requirements, and restrictive covenants in our revolving credit facility,
    term loan and the indenture for our 7 3/8% senior notes;
*   changes in product mix to less profitable products;
*   the retention and availability of key personnel;
    changes in the legal, regulatory and political environment that impact, or
    will impact, our business, including changes to customs or trade
*   regulations, laws or regulations relating to ingredients or other
    chemicals or raw materials contained in products or packaging, or
    accounting standards or critical accounting estimates;
    the success of our global Elizabeth Arden brand repositioning efforts;
*
    the impact of tax audits, including the ultimate outcome of the pending
*   Internal Revenue Service examination of our U.S. federal tax returns for
    the fiscal years ended June 30, 2008 and June 30, 2009, changes in tax
    laws or tax rates, and our ability to utilize our deferred tax assets;
    our ability to effectively implement, manage and maintain our global
    information systems and maintain the security of our confidential data and
*   our employees' and customers' personal information; including our ability
    to successfully and cost-effectively implement the last phase of our
    Oracle financial accounting and order processing system;
    our reliance on third parties for certain outsourced business services,
*   including information technology operations and employee benefit plan
    administration;
    the potential for significant impairment charges relating to our
*   trademarks, goodwill or other intangible assets that could result from a
    number of factors, including downward pressure on our stock price; and
*   other unanticipated risks and uncertainties.

We caution that the factors described herein could cause actual results to
differ materially from those expressed in any forward-looking statements we
make and that investors should not place undue reliance on any such
forward-looking statements. Further, any forward-looking statement speaks only
as of the date on which such statement is made, and we undertake no obligation
to update any forward-looking statement to reflect events or circumstances
after the date on which such statement is made or to reflect the occurrence of
anticipated or unanticipated events or circumstances. New factors emerge from
time to time, and it is not possible for us to predict all of such factors.
Further, we cannot assess the impact of each such factor on our results of
operations or the extent to which any factor, or combination of factors, may
cause actual results to differ materially from those contained in any
forward-looking statements. This press release is qualified in its entirety by
the cautionary statements and risk factor disclosure contained in our
Securities and Exchange Commission filings, including our Annual Report on
Form 10-K for the year ended June 30, 2012.

Contact:

Company Contact:
Elizabeth Arden, Inc.
Marcey Becker, Senior Vice President, Finance
or
Investor/Press Contact:
Integrated Corporate Relations
Allison Malkin/Michael Fox, (203) 682-8200
 
Press spacebar to pause and continue. Press esc to stop.